Feasible economic strategies to improve screening compliance for colorectal cancer in Korea

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

277

HTML

2911

Figures (1-1)

322

Tables (1-4)

267

Sum=3777

Mar 21, 2005 (publication date) through Feb 12, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Colorectal Cancer

World J Gastroenterol. Mar 21, 2005; 11(11): 1587-1593
Published online Mar 21, 2005. doi: 10.3748/wjg.v11.i11.1587

Table 3 Cost-effectiveness of 16 strategies of colorectal screening among Korean adults with changing NHI¹ coverage and compliance.

Strategy (abbreviation)	Lifetime cost per person, won²	Lifetime financial burden of NHI¹, won²	Incremental C/E³, won² per life-year gained	Strategy (abbreviation)	Lifetime cost per person, won²	Lifetime financial burden of NHI¹, won²	Incremental C/E³, won² per life-year gained
	NHI¹ coverage = 50%				NHI¹ coverage = 100%
	Screening compliance = 45%,				Screening compliance = 60%,
	Follow-up compliance = 65%				Follow-up compliance = 80%
COL10	310354	178233		COL10	307395	226848
COL5	311640	188051	93440	COL at 55	308933	192405	(Dominated)
COL at 55	321624	172824	(Dominated)⁴	SIG5	316541	235951	(Dominated)
SIG3	328365	197511	(Dominated)	SIG10	321728	214095	(Dominated)
SIG5	332244	191881	(Dominated)	SIG3	323691	261056	(Extended Dominated)⁵
COL3	336101	207072	2113350	COL5	325435	267054	1371670
SIG10	339760	186587	(Dominated)	SIG at 55	330560	191573	(Dominated)
SIG at 55	347179	181334	(Dominated)	FOBT2	370827	216521	(Dominated)
SIG5+DCBE5	369225	213205	(Dominated)	No screening	370968	185809	(Dominated)
No screening	370847	185499	(Dominated)	COL3	374192	323357	5656770
FOBT2	373988	208794	(Dominated)	FOBT1+SIG5	382870	277687	(Dominated)
FOBT1+SIG5	380512	238067	(Dominated)	SIG5+DCBE5	383934	303581	(Dominated)
FOBT1	388456	234316	(Dominated)	FOBT1	389668	248595	(Dominated)
DCBE10	394938	209420	(Dominated)	DCBE10	397017	260523	(Dominated)
DCBE5	420550	229974	(Dominated)	DCBE5	429376	316022	(Dominated)
DCBE3	455758	255914	(Dominated)	DCBE3	478144	384805	(Dominated)

COL, colonoscopy; SIG, sigmoidoscopy; DCBE, double contrast barium enema; FOBT, fecal occult blood test.

¹National Health Insurance of Korea.

²Exchange rate: 1 200 Korean won for one US dollar.

³Incremental CE ratio (won/year) = Incremental cost per person/incremental days of life gained×365 d.

⁴Dominated strategy is a strategy that is more or equally costly and less effective than a competing strategy.

⁵Extended dominated: Extended dominated strategy is a strategy which is less effective and had a higher ICER than another strategy.

Citation: Park SM, Yun YH, Kwon S. Feasible economic strategies to improve screening compliance for colorectal cancer in Korea. World J Gastroenterol 2005; 11(11): 1587-1593
URL: https://www.wjgnet.com/1007-9327/full/v11/i11/1587.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i11.1587